m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00422)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
TACC3
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
RNA demethylase ALKBH5 (ALKBH5) [ERASER]
Representative RNA-seq result indicating the expression of this target gene regulated by ALKBH5 | ||
Cell Line | HaCAT cell line | Homo sapiens |
Treatment: siALKBH5 HaCAT cells
Control: siControl HaCAT cells
|
GSE211076 | |
Regulation |
|
logFC: 7.07E-01 p-value: 2.85E-14 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | ALKBH5 exerts tumor-promoting effects in acute myeloid leukemia by post-transcriptional regulation of its critical targets such as Transforming acidic coiled-coil-containing protein 3 (TACC3), a prognosis-associated oncogene in various cancers. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Acute myeloid leukaemia | ICD-11: 2A60 | ||
Pathway Response | Signaling pathways regulating pluripotency of stem cells | hsa04550 | ||
Cell Process | Self-renewal | |||
In-vitro Model | HEK293T | Normal | Homo sapiens | CVCL_0063 |
MOLM-13 | Adult acute myeloid leukemia | Homo sapiens | CVCL_2119 | |
Mono-Mac-6 | Adult acute monocytic leukemia | Homo sapiens | CVCL_1426 | |
MV4-11 | Childhood acute monocytic leukemia | Homo sapiens | CVCL_0064 | |
NB4 | Acute promyelocytic leukemia | Homo sapiens | CVCL_0005 | |
NOMO-1 | Adult acute monocytic leukemia | Homo sapiens | CVCL_1609 | |
THP-1 | Childhood acute monocytic leukemia | Homo sapiens | CVCL_0006 | |
U-937 | Adult acute monocytic leukemia | Homo sapiens | CVCL_0007 | |
In-vivo Model | gRNA and Cas9 mRNA were mixed at concentration of 50 and 100 ng/ul, respectively, and injected to the cytoplasm of one-cell-stage embryos of C57BL/6 genetic background. | |||
Acute myeloid leukaemia [ICD-11: 2A60]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | ALKBH5 exerts tumor-promoting effects in acute myeloid leukemia by post-transcriptional regulation of its critical targets such as Transforming acidic coiled-coil-containing protein 3 (TACC3), a prognosis-associated oncogene in various cancers. | |||
Responsed Disease | Acute myeloid leukaemia [ICD-11: 2A60] | |||
Target Regulator | RNA demethylase ALKBH5 (ALKBH5) | ERASER | ||
Target Regulation | Up regulation | |||
Pathway Response | Signaling pathways regulating pluripotency of stem cells | hsa04550 | ||
Cell Process | Self-renewal | |||
In-vitro Model | HEK293T | Normal | Homo sapiens | CVCL_0063 |
MOLM-13 | Adult acute myeloid leukemia | Homo sapiens | CVCL_2119 | |
Mono-Mac-6 | Adult acute monocytic leukemia | Homo sapiens | CVCL_1426 | |
MV4-11 | Childhood acute monocytic leukemia | Homo sapiens | CVCL_0064 | |
NB4 | Acute promyelocytic leukemia | Homo sapiens | CVCL_0005 | |
NOMO-1 | Adult acute monocytic leukemia | Homo sapiens | CVCL_1609 | |
THP-1 | Childhood acute monocytic leukemia | Homo sapiens | CVCL_0006 | |
U-937 | Adult acute monocytic leukemia | Homo sapiens | CVCL_0007 | |
In-vivo Model | gRNA and Cas9 mRNA were mixed at concentration of 50 and 100 ng/ul, respectively, and injected to the cytoplasm of one-cell-stage embryos of C57BL/6 genetic background. | |||